EMJ GOLD - European Medical Journal

This site is intended for healthcare professionals

Continue

EMJ GOLD

Filter Advertise With Us
Brazil and South African Flags on map to signify where Aspen has got approval to sell generic injectable semaglutide

Aspen wins generic semaglutide approval in Brazil and South Africa

Aspen secures generic semaglutide approvals in Brazil and South Africa, with launches expected in the coming months.
Vaccines being manufactured by AstraZeneca in collaboration with Ominiose

AstraZeneca buys Omniose to boost bacterial vaccine pipeline

AstraZeneca acquires US biotech Omniose, adding technology to support bacterial vaccine development.
Novartis drug maker under investigation by FDA for gene therapy links to tumours in children

FDA investigates Novartis gene therapy link to tumours in children

FDA investigates tumours linked to Novartis’s SMA gene therapy Zolgensma as patient groups demand clearer information.
Wegovy and Ozempic injectable drugs and Wegovy pills

Lilly strikes obesity drug access deal with Hims & Hers telehealth

Hims & Hers will now offer Lilly’s Zepbound and Foundayo directly through its platform at LillyDirect self-pay prices.
Doctor doing vaccination injection

UK industry clinical trial recruitment falls for fifth year

The number of patients taking part in industry-sponsored clinical trials in the UK has fallen, despite improvements elsewhere.
Mnth in pharma news explained October 2026

Month in pharma news, explained – October 2026

Successful trials for an emerging drug class, plummeting shares for Moderna after a data leak and generation-defining new nerve technology. Discover this month in pharma.
Medical hand glove blue molding vial vaccine hypodermic needle syringe injection treatment

First generic HIV prevention injection clears FDA hurdle

The FDA has granted tentative approval to Dr. Reddy’s Laboratories for the first generic version of injectable lenacapavir for HIV prevention.
AstraZeneca glass bottle with drug in it

AstraZeneca targets $1.5bn annual savings to support pipeline

AstraZeneca plans $1.5bn in annual savings to support pipeline investment after quarterly results beat forecasts.
We’ve noticed you’re accessing
from North/South America.